- Home
- Publications
- Publication Search
- Publication Details
Title
Modes of action of TLR7 agonists in cancer therapy
Authors
Keywords
-
Journal
Immunotherapy
Volume 6, Issue 10, Pages 1085-1095
Publisher
Future Medicine Ltd
Online
2014-11-27
DOI
10.2217/imt.14.75
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Topical rather than intradermal application of the TLR7 ligand imiquimod leads to human dermal dendritic cell maturation and CD8+T-cell cross-priming
- (2014) Cynthia M. Fehres et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A novel systemically administered toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models
- (2014) Amy L. Adlard et al. INTERNATIONAL JOURNAL OF CANCER
- Immunization of Malignant Melanoma Patients with Full-Length NY-ESO-1 Protein Using TLR7 Agonist Imiquimod as Vaccine Adjuvant
- (2014) S. Adams et al. JOURNAL OF IMMUNOLOGY
- Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205
- (2014) M. V. Dhodapkar et al. Science Translational Medicine
- Direct Type I IFN but Not MDA5/TLR3 Activation of Dendritic Cells Is Required for Maturation and Metabolic Shift to Glycolysis after Poly IC Stimulation
- (2014) Austin Pantel et al. PLOS BIOLOGY
- TLR7 Expression is Decreased During Tumour Progression in Transgenic Adenocarcinoma of Mouse Prostate Mice and Its Activation Inhibits Growth of Prostate Cancer Cells
- (2013) Ju-Hee Han et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Tumor Promotion by Intratumoral Plasmacytoid Dendritic Cells Is Reversed by TLR7 Ligand Treatment
- (2013) I. Le Mercier et al. CANCER RESEARCH
- Topical and Intralesional Treatment of Nonmelanoma Skin Cancer: Efficacy and Cost Comparisons
- (2013) Katelyn Chitwood et al. DERMATOLOGIC SURGERY
- Toll-like receptors as therapeutic targets for cancer
- (2013) Johanna Holldack DRUG DISCOVERY TODAY
- GS-9620, an Oral Agonist of Toll-Like Receptor-7, Induces Prolonged Suppression of Hepatitis B Virus in Chronically Infected Chimpanzees
- (2013) Robert E. Lanford et al. GASTROENTEROLOGY
- Targeting Uptake Receptors on Human Plasmacytoid Dendritic Cells Triggers Antigen Cross-Presentation and Robust Type I IFN Secretion
- (2013) J. Tel et al. JOURNAL OF IMMUNOLOGY
- B Cell-Intrinsic TLR7 Signaling Is Required for Optimal B Cell Responses during Chronic Viral Infection
- (2013) J. M. Clingan et al. JOURNAL OF IMMUNOLOGY
- Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial
- (2013) Aimée HMM Arits et al. LANCET ONCOLOGY
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets
- (2012) J. Tel et al. BLOOD
- Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma
- (2012) S. J. Dovedi et al. BLOOD
- TLR8: the forgotten relative revindicated
- (2012) Jorge L Cervantes et al. Cellular & Molecular Immunology
- Dendritic Cell-Activating Vaccine Adjuvants Differ in the Ability to Elicit Antitumor Immunity Due to an Adjuvant-Specific Induction of Immunosuppressive Cells
- (2012) Y. Dang et al. CLINICAL CANCER RESEARCH
- Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
- (2012) S. Adams et al. CLINICAL CANCER RESEARCH
- Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer
- (2012) M. Z. Dewan et al. CLINICAL CANCER RESEARCH
- Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+T-cell responses in melanoma patients
- (2012) Simone M. Goldinger et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Intratracheal and oral administration of SM-276001: A selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer
- (2012) Erina Koga-Yamakawa et al. INTERNATIONAL JOURNAL OF CANCER
- Synergistical toll-like receptors activated dendritic cells induce antitumor effects against carcinoembryonic antigen-expressing colon cancer
- (2012) Xinqiang Hong et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells
- (2012) Barbara Drobits et al. JOURNAL OF CLINICAL INVESTIGATION
- Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans
- (2012) Atsuo Ochi et al. JOURNAL OF CLINICAL INVESTIGATION
- A Combination of Local Inflammation and Central Memory T Cells Potentiates Immunotherapy in the Skin
- (2012) S. Fiorenza et al. JOURNAL OF IMMUNOLOGY
- TRAIL+ Human Plasmacytoid Dendritic Cells Kill Tumor Cells In Vitro: Mechanisms of Imiquimod- and IFN- -Mediated Antitumor Reactivity
- (2012) M. L. Kalb et al. JOURNAL OF IMMUNOLOGY
- Type I IFN Receptor and the B Cell Antigen Receptor Regulate TLR7 Responses via Distinct Molecular Mechanisms
- (2012) J. S. Poovassery et al. JOURNAL OF IMMUNOLOGY
- Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine
- (2012) Anna Wolska et al. LEUKEMIA & LYMPHOMA
- Le récepteur Toll-like8
- (2012) Lena Alexopoulou et al. M S-MEDECINE SCIENCES
- Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
- (2012) Steffen Walter et al. NATURE MEDICINE
- Sex Differences in the Response to Viral Infections: TLR8 and TLR9 Ligand Stimulation Induce Higher IL10 Production in Males
- (2012) Maria Gabriella Torcia et al. PLoS One
- Regulation of TLR7/9 signaling in plasmacytoid dendritic cells
- (2012) Musheng Bao et al. Protein & Cell
- The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor signaling
- (2011) C. Seillet et al. BLOOD
- Systemic Cancer Therapy with a Small Molecule Agonist of Toll-like Receptor 7 Can Be Improved by Circumventing TLR Tolerance
- (2011) C. Bourquin et al. CANCER RESEARCH
- Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors
- (2011) F. Aranda et al. CANCER RESEARCH
- Phase I Study Utilizing a Novel Antigen-Presenting Cell-Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients
- (2011) M. A. Morse et al. CLINICAL CANCER RESEARCH
- Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity
- (2011) Takumi Kawasaki et al. IMMUNOLOGICAL REVIEWS
- Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase
- (2011) Sarah E. Ewald et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Topical Imiquimod has Therapeutic and Immunomodulatory Effects Against Intracranial Tumors
- (2011) Zhengming Xiong et al. JOURNAL OF IMMUNOTHERAPY
- Immunomodulation by Imiquimod in Patients with High-Risk Primary Melanoma
- (2011) Rupa Narayan et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remission
- (2011) Barbara Beck et al. Journal of Translational Medicine
- The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system
- (2011) Abbi L Engel et al. Expert Review of Clinical Pharmacology
- Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists
- (2010) D. Rajagopal et al. BLOOD
- Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers
- (2010) Melissa A. Geller et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice
- (2010) Fang Ma et al. Cellular & Molecular Immunology
- Stimulation of the endosomal TLR pathway enhances autophagy-induced cell death in radiotherapy of breast cancer
- (2010) Su-Jin Kang et al. Genes & Genomics
- Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance
- (2010) Julien Cherfils-Vicini et al. JOURNAL OF CLINICAL INVESTIGATION
- Treatment Failure of a TLR-7 Agonist Occurs Due to Self-Regulation of Acute Inflammation and Can Be Overcome by IL-10 Blockade
- (2010) H. Lu et al. JOURNAL OF IMMUNOLOGY
- The TLR7 Agonist R848 Alleviates Allergic Inflammation by Targeting Invariant NKT Cells To Produce IFN-
- (2010) F. Grela et al. JOURNAL OF IMMUNOLOGY
- Delivery of Immunostimulatory RNA Oligonucleotides by Gelatin Nanoparticles Triggers an Efficient Antitumoral Response
- (2010) Carole Bourquin et al. JOURNAL OF IMMUNOTHERAPY
- Enhanced Tumor Eradication by Combining CTLA-4 or PD-1 Blockade With CpG Therapy
- (2010) Sara M. Mangsbo et al. JOURNAL OF IMMUNOTHERAPY
- Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity
- (2010) Mariola Fotin-Mleczek et al. JOURNAL OF IMMUNOTHERAPY
- Antitumor Activity and Immune Response Induction of a Dual Agonist of Toll-Like Receptors 7 and 8
- (2010) D. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signalling
- (2010) Su-Chang Lin et al. NATURE
- The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells
- (2009) Evelien L. J. M. Smits et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Toll-like Receptors 3 and 7 Agonists Enhance Tumor Cell Lysis by Human T Cells
- (2009) H. Shojaei et al. CANCER RESEARCH
- Selective and direct activation of human neutrophils but not eosinophils by Toll-like receptor 8
- (2009) Markus Janke et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Immunostimulatory RNA Oligonucleotides Induce an Effective Antitumoral NK Cell Response through the TLR7
- (2009) C. Bourquin et al. JOURNAL OF IMMUNOLOGY
- Locally Administered TLR7 Agonists Drive Systemic Antitumor Immune Responses That Are Enhanced by Anti-CD40 Immunotherapy
- (2009) S. A. Broomfield et al. JOURNAL OF IMMUNOLOGY
- Murine B Cell Response to TLR7 Ligands Depends on an IFN- Feedback Loop
- (2009) N. M. Green et al. JOURNAL OF IMMUNOLOGY
- Selection of Molecular Structure and Delivery of RNA Oligonucleotides to Activate TLR7 versus TLR8 and to Induce High Amounts of IL-12p70 in Primary Human Monocytes
- (2009) A. Ablasser et al. JOURNAL OF IMMUNOLOGY
- Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists
- (2009) Svetlana Hamm et al. Journal of Immunotoxicology
- Imiquimod Enhances IFN-γ Production and Effector Function of T Cells Infiltrating Human Squamous Cell Carcinomas of the Skin
- (2009) Susan J. Huang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A five-amino-acid motif in the undefined region of the TLR8 ectodomain is required for species-specific ligand recognition
- (2009) Jin Liu et al. MOLECULAR IMMUNOLOGY
- Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1
- (2009) Angela Meier et al. NATURE MEDICINE
- NK1.1+ cells mediate the antitumor effects of a dual Toll-like receptor 7/8 agonist in the disseminated B16-F10 melanoma model
- (2008) Calin D. Dumitru et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- An Exploratory Study of Systemic Administration of the Toll-like Receptor-7 Agonist 852A in Patients with Refractory Metastatic Melanoma
- (2008) R. Dummer et al. CLINICAL CANCER RESEARCH
- Crosstalk between components of the innate immune system: promoting anti-microbial defenses and avoiding immunopathologies
- (2008) Karine Crozat et al. IMMUNOLOGICAL REVIEWS
- Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells
- (2008) Rachael A. Clark et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TLR7 Agonist 852A Inhibition of Tumor Cell Proliferation Is Dependent on Plasmacytoid Dendritic Cells and Type I IFN
- (2008) Jon R. Inglefield et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Signalling pathways leading to IFN-α production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications
- (2008) C. Guiducci et al. JOURNAL OF INTERNAL MEDICINE
- UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes
- (2008) You-Me Kim et al. NATURE
- The Use of TLR7 and TLR8 Ligands for the Enhancement of Cancer Immunotherapy
- (2008) E. L. J. M. Smits et al. ONCOLOGIST
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now